UK Government backs 44 recommendations for AI in healthcare

NHS: The NHS is the United Kingdom's publicly funded national healthcare system delivering services to patients. It participates in cross-government initiatives to implement AI regulations, focusing on equitable access, transparency, and workforce readiness for new technologies. Collaboration with the NHS supports real-world testing and safe deployment of AI tools. James Frith: James Frith is the UK Health innovation minister focused on advancing healthcare technologies. He highlighted the government's support for AI literacy among professionals and opportunities for testing tools that benefit patients directly. His comments underscore a commitment to evolving regulations that balance opportunity with strong safeguards and transparency. UK Government: The UK Government is the central executive authority responsible for national policy across sectors including healthcare and technology. It has accepted in full the recommendations from the National Commission into the Regulation of AI in Healthcare to promote safe and effective AI use in medical settings. This involves coordinated efforts with agencies to modernize regulations, support workforce training, and ensure patient safety alongside innovation. Lawrence Tallon: Lawrence Tallon is the chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA). He expressed support for the government's response to the commission's recommendations and outlined plans for clearer implementation. He noted the AI Airlock program's expansion to help innovators safely monitor and manage AI technologies over time. Medicines and Healthcare products Regulatory Agency: The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK body responsible for regulating medicines, medical devices, and related technologies. It is leading work on AI-enabled device frameworks, including draft guidance and consultations on classification, while operating the AI Airlock regulatory sandbox. The agency is advancing post-market surveillance to monitor AI tools throughout their lifecycle. National Commission into the Regulation of AI in Healthcare: The National Commission into the Regulation of AI in Healthcare is an independent body that examined and proposed guidelines for AI oversight in medical contexts. It developed recommendations emphasizing people-centered approaches with systems that are safe, fast, and trusted. The government has endorsed these to form the foundation for AI integration in healthcare. Workforce: Work is underway across government, the MHRA, NHS and devolved authorities to build system capability including training the healthcare workforce for widespread AI adoption. Innovation: The MHRA has opened applications for the third phase of its AI Airlock sandbox, which focuses on post-market surveillance and lifecycle management of AI-enabled medical devices. Regulation: The government is creating a cross-system programme board with partner organizations to meet quarterly and coordinate AI regulation efforts while identifying emerging risks.